(UroToday.com) Today at the Engineering and Urology Society (EUS) Poster Session, Dr. Dan Stoianovici presented early clinical experience with ProBot, a newly developed robotic system designed to ...

While MRI-targeted biopsy (TB) has improved prostate cancer detection, systematic biopsy (SB) remains a critical complementary approach, often identifying csPCa missed by TB. However, the optimal ...

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...